Systemic immune-checkpoint blockade with anti-PD1 antibodies does not alter cerebral amyloid-β burden in several amyloid transgenic mouse models.

about

Lymphocyte activation gene 3 (Lag3) expression is increased in prion infections but does not modify disease progression PD-1 deficiency is not sufficient to induce myeloid mobilization to the brain or alter the inflammatory profile during chronic neurodegeneration

P2860

Q57050465-81F7AA80-1748-4BA2-BB12-4B53DFCD2F55 Q58791590-ED223EC3-C71E-4DDC-B5CA-D493416CD36C

P2860

Systemic immune-checkpoint blockade with anti-PD1 antibodies does not alter cerebral amyloid-β burden in several amyloid transgenic mouse models.

Item

http://www.wikidata.org/entity/Q47602416

description

2017 nî lūn-bûn

@nan

2017年の論文

@ja

2017年学术文章

@wuu

2017年学术文章

@zh-cn

2017年学术文章

@zh-hans

2017年学术文章

@zh-my

2017年学术文章

@zh-sg

2017年學術文章

@yue

2017年學術文章

@zh

2017年學術文章

@zh-hant

name

Systemic immune-checkpoint blo ...... yloid transgenic mouse models.

@en

Systemic immune-checkpoint blo ...... yloid transgenic mouse models.

@nl

type

Item

label

Systemic immune-checkpoint blo ...... yloid transgenic mouse models.

@en

Systemic immune-checkpoint blo ...... yloid transgenic mouse models.

@nl

prefLabel

Systemic immune-checkpoint blo ...... yloid transgenic mouse models.

@en

Systemic immune-checkpoint blo ...... yloid transgenic mouse models.

@nl

P1476

Systemic immune-checkpoint blo ...... yloid transgenic mouse models.

@en

P2093

Alexis Bretteville

http://www.w3.org/2001/XMLSchema#string

Andreas Ebneth

http://www.w3.org/2001/XMLSchema#string

Astrid Bottelbergs

http://www.w3.org/2001/XMLSchema#string

Bart Roucourt

http://www.w3.org/2001/XMLSchema#string

Bradford Elmer

http://www.w3.org/2001/XMLSchema#string

Caroline Hersley

http://www.w3.org/2001/XMLSchema#string

Cindy Wintmolders

http://www.w3.org/2001/XMLSchema#string

David R Riddell

http://www.w3.org/2001/XMLSchema#string

Emmanuel Brault

http://www.w3.org/2001/XMLSchema#string

Jirong Lu

http://www.w3.org/2001/XMLSchema#string

P2860

Alzheimer-type neuropathology in transgenic mice overexpressing V717F β-amyloid precursor protein

Mechanisms of Aβ Clearance and Degradation by Glial Cells

Reduced β-amyloid pathology in an APP transgenic mouse model of Alzheimer's disease lacking functional B and T cells

The blockade of immune checkpoints in cancer immunotherapy

Mutant presenilins specifically elevate the levels of the 42 residue beta-amyloid peptide in vivo: evidence for augmentation of a 42-specific gamma secretase

A beta peptide immunization reduces behavioural impairment and plaques in a model of Alzheimer's disease.

Six red flags for suspect work.

PD-1 immune checkpoint blockade reduces pathology and improves memory in mouse models of Alzheimer's disease.

Systemic transplantation of human umbilical cord derived mesenchymal stem cells-educated T regulatory cells improved the impaired cognition in AβPPswe/PS1dE9 transgenic mice.

Abeta42-driven cerebral amyloidosis in transgenic mice reveals early and robust pathology.

P304

492-504

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1002/GLIA.23260

http://www.w3.org/2001/XMLSchema#string

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P50

Gary Nabel

Zhi-Yong Yang

P577

2017-11-14T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

29134678

http://www.w3.org/2001/XMLSchema#string

Systemic immune-checkpoint blockade with anti-PD1 antibodies does not alter cerebral amyloid-β burden in several amyloid transgenic mouse models.

about

P2860

P2860

Systemic immune-checkpoint blockade with anti-PD1 antibodies does not alter cerebral amyloid-β burden in several amyloid transgenic mouse models.

description

name

type

label

prefLabel

P1433

P1476

P2093

P2860

P304

P31

P356

P433

P478

P50

P577

P698

P356

P1433

P1476

P2093

P2860

P304

P31

P356

P433

P478

P50

P577

P698